Literature DB >> 12911097

Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis.

Frederieke M Brouwers1, Wim J G Oyen, Otto C Boerman, John A Barrett, Freek W A Verheugt, Frans H M Corstens, Jos W M Van der Meer.   

Abstract

PURPOSE: Infective endocarditis (IE) is characterized by aggregation of activated platelets, fibrin, and bacteria. DMP444, a high-affinity glycoprotein IIb/IIIa receptor antagonist, binds to the fibrinogen-binding domain of activated platelets, depicting a key feature of IE. Tc-99m DMP444 scintigraphy was studied in a group of patients with possible IE.
METHODS: Tc-99m DMP444 (600 MBq; 16 mCi) planar and SPECT images of the heart were recorded in patients with possible IE for as long as 6 hours after injection. Results were compared to echocardiography and the Duke classification.
RESULTS: Sixteen patients (age range, 37 to 78 years) participated. DMP444 imaging was positive on SPECT in five patients, and all had definite endocarditis (affecting both prosthetic and native valves). Eleven patients were DMP444 negative, seven with no proof of IE. The remaining four patients were classified as having IE, but three had been receiving adequate intravenous antibiotic regimens for > or = 2 weeks at the time of scintigraphy and one had Q-fever endocarditis.
CONCLUSIONS: DMP444 SPECT allows in vivo visualization of IE if it is performed within 1 to 2 weeks after the start of antibiotic treatment. Given the high affinity of DMP444 for activated platelets, the results indicate the involvement of activated platelets in early IE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911097     DOI: 10.1097/01.RLU.0000067508.82824.75

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

Review 1.  The role of molecular imaging in diagnosis of deep vein thrombosis.

Authors:  Sina Houshmand; Ali Salavati; Søren Hess; Mudalsha Ravina; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

Review 2.  Endocarditis and molecular imaging.

Authors:  Peter Panizzi; James R Stone; Matthias Nahrendorf
Journal:  J Nucl Cardiol       Date:  2014-05-06       Impact factor: 5.952

3.  Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444.

Authors:  Wei Fang; Jia He; Young-Seung Kim; Yang Zhou; Shuang Liu
Journal:  Bioconjug Chem       Date:  2011-08-02       Impact factor: 4.774

Review 4.  Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2015-08-03       Impact factor: 4.774

5.  Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.

Authors:  Yang Zhou; Sudipta Chakraborty; Shuang Liu
Journal:  Theranostics       Date:  2011-01-18       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.